Pharmacoepidemiology

Home/Pharmacoepidemiology

Thanks for the large attendance during our breakout session at ISPOR

2019-11-08T12:53:22+01:00November 8th, 2019|Categories: Cancer, Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Thanks for the large attendance during our breakout session at ISPOR in Copenhagen regarding pooling Nordic register data! We find it rewarding to share our experiences and our extensive know-how from 10 years of doing these unique studies. ApHER also presented two posters during the conference, using Danish data on Sclerosis in one study and Swedish [...]

ApHER conducted analyses in a project recently presented at ISPOR 2019, New Orleans

2019-06-20T11:25:27+01:00June 20th, 2019|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Anastasija Komkova and Thomas Fast from ApHER conducted analyses in a research project examining the healthcare resource utilization and medication burden in epilepsy patients before and after initiating the antiepileptic drug perampanel. The project was presented in a poster at ISPOR 2019 in New Orleans, LA, on May 18-22. Further information and link for the poster [...]

Nordic Evidence Leaders Forum – Stockholm May 14-15 2019

2019-05-20T13:26:08+01:00May 20th, 2019|Categories: Health Economics, Nordic Health Registers, Pharmacoepidemiology, Uncategorised|

Thomas was a speaker at the Nextlevel Life Sciences Conference in Stockholm in May 2019. During the conference, Thomas shared ApHER´s experience of pooling Nordic data

Meet Thomas Fast from ApHER at the Nordic Evidence Leaders Forum in Stockholm

2019-03-18T11:03:08+01:00March 18th, 2019|Categories: Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Demonstrating the safety profile of a new drug intervention is a pre-requisite for market access. Thomas will introduce the structure of Nordic health register data with a case on how a multi-country safety study was developed to support market access by including health economic aspects in the study design. The Nordic region is regarded as one [...]

New publication: Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.

2018-12-04T15:59:31+01:00December 4th, 2018|Categories: Cancer, Nordic Health Registers, Pharmacoepidemiology|

By pooling Nordic health data on medical devices & pharmaceuticals, and analyzing it on the micro-level, we tap into the full potential of big data. The Nordic health registers cover 26 mill. people from birth to death. Read about our most recent safety study, pooling data from 4 Nordic countries, here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773955/ 

New study: Many patients go for years without seeing a sclerosis doctor

2018-09-28T14:14:20+01:00April 6th, 2018|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]

Annual meeting of the Scandinavian Society for the study of diabetes

2018-08-03T15:26:33+01:00May 21st, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers, Pharmacoepidemiology|

Professor Anders Green gave an invited presentation on the epidemiological results from the Diabetes Impact Study in connection with the Annual Meeting of the Scandinavian Society for the Study of Diabetes, held the 19th-21st of May in Nyborg (Denmark).